Immuno-Oncology Assays Market Size, Share & Trends Analysis Report By Products & Services (Consumables, Instruments, Software & Services), By Technology (PCR, Immunoassay, NGS, ISH, Flow Cytometry), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma, Others), By Application (Research Applications, Clinical Diagnostics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: February 16, 2026 | Author: Debashree B | Format: | Report Code: SR4348DR | Pages: 150

Market Segmentation

  1. Immuno-Oncology Assays Market, By Products & Services 2022-2034 (USD MILLION/ Units)
    1. Consumables
    2. Instruments
    3. Software & Services
  2. Immuno-Oncology Assays Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. PCR
    2. Immunoassay
    3. NGS
    4. ISH
    5. Flow Cytometry
  3. Immuno-Oncology Assays Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Lung Cancer
    2. Breast Cancer
    3. Colorectal Cancer
    4. Bladder Cancer
    5. Melanoma
    6. Others
  4. Immuno-Oncology Assays Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Research Applications
    2. Clinical Diagnostics
  5. Regional Immuno-Oncology Assays Market
    1. North America
      1. North America Immuno-Oncology Assays Market By Products & Services 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Software & Services
      2. North America Immuno-Oncology Assays Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. Immunoassay
        3. NGS
        4. ISH
        5. Flow Cytometry
      3. North America Immuno-Oncology Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Bladder Cancer
        5. Melanoma
        6. Others
      4. North America Immuno-Oncology Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Research Applications
        2. Clinical Diagnostics
      5. U.S.
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      6. Canada
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
    2. Europe
      1. Europe Immuno-Oncology Assays Market By Products & Services 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Software & Services
      2. Europe Immuno-Oncology Assays Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. Immunoassay
        3. NGS
        4. ISH
        5. Flow Cytometry
      3. Europe Immuno-Oncology Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Bladder Cancer
        5. Melanoma
        6. Others
      4. Europe Immuno-Oncology Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Research Applications
        2. Clinical Diagnostics
      5. U.K.
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      6. Germany
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      7. France
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      8. Spain
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      9. Italy
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      10. Russia
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      11. Nordic
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      12. Benelux
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      13. Rest of Europe
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
    3. APAC
      1. APAC Immuno-Oncology Assays Market By Products & Services 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Software & Services
      2. APAC Immuno-Oncology Assays Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. Immunoassay
        3. NGS
        4. ISH
        5. Flow Cytometry
      3. APAC Immuno-Oncology Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Bladder Cancer
        5. Melanoma
        6. Others
      4. APAC Immuno-Oncology Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Research Applications
        2. Clinical Diagnostics
      5. China
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      6. Korea
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      7. Japan
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      8. India
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      9. Australia
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      10. Taiwan
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      11. South East Asia
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      12. Rest of Asia-Pacific
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
    4. Middle East and Africa
      1. Middle East and Africa Immuno-Oncology Assays Market By Products & Services 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Software & Services
      2. Middle East and Africa Immuno-Oncology Assays Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. Immunoassay
        3. NGS
        4. ISH
        5. Flow Cytometry
      3. Middle East and Africa Immuno-Oncology Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Bladder Cancer
        5. Melanoma
        6. Others
      4. Middle East and Africa Immuno-Oncology Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Research Applications
        2. Clinical Diagnostics
      5. UAE
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      6. Turkey
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      7. Saudi Arabia
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      8. South Africa
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      9. Egypt
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      10. Nigeria
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      11. Rest of MEA
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
    5. LATAM
      1. LATAM Immuno-Oncology Assays Market By Products & Services 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Software & Services
      2. LATAM Immuno-Oncology Assays Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. Immunoassay
        3. NGS
        4. ISH
        5. Flow Cytometry
      3. LATAM Immuno-Oncology Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Bladder Cancer
        5. Melanoma
        6. Others
      4. LATAM Immuno-Oncology Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Research Applications
        2. Clinical Diagnostics
      5. Brazil
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      6. Mexico
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      7. Argentina
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      8. Chile
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      9. Colombia
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
      10. Rest of LATAM
        1. Consumables
        2. Instruments
        3. Software & Services
        4. PCR
        5. Immunoassay
        6. NGS
        7. ISH
        8. Flow Cytometry
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Bladder Cancer
        13. Melanoma
        14. Others
        15. Research Applications
        16. Clinical Diagnostics
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: